Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: erin4 who wrote (1309)	7/19/1998 12:37:00 PM
From: Selk	Read Replies (1) \| Respond to of 4650

Perhaps Mr Ma'ayam is irritated that Mr. Robins' ADOT should be more focused on the development and production of their displays, rather than riding on the coat tails of Biomoda. Majority of press releases are in reference to Biomoda. Looks like at the present time, Biomoda is proceeding forward and ADOT is at a standstill. ADOT needs to let the world know of ITS product and actually be taken out of a development and laboratory environment and into the real world of production. Let's see some news about the billboards and the display technology! Biomoda appears to have real interest in their product....would like to see the same interest in the ADOT product! Selk

To: erin4 who wrote (1309)	7/19/1998 1:01:00 PM
From: Thomas Clawson	Read Replies (1) \| Respond to of 4650

I am going to give you guys something else to think about! I have done some really indepth research on the ADOT/Biomoda thing and here are my conclusions: Biomoda is closer to success than we have been lead to believe. ADOT was made aware of this by Dr. Ellingwood, who is a "scientific advisor" to Biomoda, i.e. a consultant, not a Biomoda employee. Both Dr Ellingwood and Leslie Robins are past employees at the Los Alamos National Labs. I'm betting they are very good friends. I am also betting that negotiations are taking place, as we ponder, between Biomoda and one or more pharmaceutical companies. The CEO of this company has better things to do right now than to keep track of how how many shares of stock an investor (ADOT) owns. He is trying to keep the lid on whats taking place while ADOT is interested in building their stock holder base. The one dealing with ADOT is the CFO of Biomoda. I own a signifcant amount of ADOT shares so if I'm wrong on this I'm going to be hurt. The reason I tell you this is to give you some idea of how indepth my research was. Good luck to all.